The Fund aims to achieve both capital growth and an attractive level of income.
Name | % Net Assets |
---|---|
Aberdeen Global II - Sterling Aggregateb | 17.5% |
Sterling Bond Fund Z-1B | 15.7% |
Dated Sterling Aggregate B | 4.6% |
Aberdeen Global II - Dated Sterling AggregateB | 3.1% |
HSBC | 2.8% |
British American Tobacco | 2.6% |
Royal Dutch Shell 'B' | 2.1% |
GlaxoSmithKline | 2.1% |
Centrica | 2.0% |
ASTRAZENECA | 2.0% |
Key | % Net Assets |
---|---|
Aberdeen Global II - Sterling Aggregateb | 17.5% |
Sterling Bond Fund Z-1B | 15.7% |
Dated Sterling Aggregate B | 4.6% |
Aberdeen Global II - Dated Sterling AggregateB | 3.1% |
Other | 59.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 110.28p |
Currency | GBP |
Change | 0.15p |
% | 0.14% |
YTD change | 0.85p |
YTD % | 0.78% |
Fund Inception | 17/11/2006 |
---|---|
Fund Manager | Aberdeen Multi-Asset |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research